An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells

Stem Cells

Volumn 32, Issue 2, 2014, Pages 327-337

  Chen, Qing ^a   Shou, Peishun ^a   Zhang, Liying ^b   Xu, Chunliang ^a   Zheng, Chunxing ^a   Han, Yanyan ^a   Li, Wenzhao ^a   Huang, Yin ^a   Zhang, Xiaoren ^a   Shao, Changshun ^c   Roberts, Arthur I ^b   Rabson, Arnold B ^b   Ren, Guangwen ^b   Zhang, Yanyun ^a   Wang, Ying ^a   Denhardt, David T ^d   Shi, Yufang ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d State University of New Jersey   (United States)

Author keywords

Adipocytes; C EBP; Differentiation; Integrins; Osteoblasts

Indexed keywords

ADIPOCYTES; C/EBP; DIFFERENTIATION; INTEGRINS; OSTEOBLASTS;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; OSTEOBLASTS; OSTEOGENESIS; OSTEOPONTIN; PROTEIN INTERACTION MAPS; RECEPTORS, VITRONECTIN;

EID: 84894562060     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1567     Document Type: Article

References (55)

1. Rosen CJ, Bouxsein ML. Mechanisms of disease: Is osteoporosis the obesity of bone? Nature Clin Pract Rheumatol 2006;2: 35-43.
2. Meunier P, Aaron J, Edouard C et al. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue-A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971;80: 147-154.
3. Gomez-Ambrosi J, Rodriguez A, Catalan V et al. The bone-adipose axis in obesity and weight loss. Obes Surg 2008;18: 1134-1143.
4. Justesen J, Stenderup K, Ebbesen EN et al. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001;2: 165-171.
5. Li XD, Jin L, Cui QJ et al. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 2005;16: 101-108.
6. Wronski TJ, Lowry PL, Walsh CC et al. Skeletal alterations in ovariectomized rats. Calcif Tissue Int 1985;37: 324-328.
7. Meirelles LDS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119: 2204-2213.
8. Ren GW, Zhang LY, Zhao X et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008;2: 141-150.
9. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
10. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284: 143-147.
11. Liu Y, Wang L, Kikuiri T et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFNgamma and TNF-alpha. Nat Med 2011;17: 1594-1601.
12. Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGF-beta family members. J Orthop Sci 2003;8: 740-748.
13. Salasznyk RM, Williams WA, Boskey A et al. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J Biomed Biotechnol 2004: 24-34.
14. Lecka-Czernik B, Moerman EJ, Grant DF et al. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002;143: 2376-2384.
15. Cheng SL, Shao JS, Charlton-Kachigian N et al. Msx2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 2003;278: 45969-45977.
16. Wang KX, Denhardt DT. Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008; 19: 333-345.
17. Denhardt DT, Noda M. Osteopontin expression and function: Role in bone remodeling. J Cell Biochem 1998;72: 92-102.
18. Wang KX, Shi YF, Denhardt DT. Osteopontin regulates hindlimb-unloading- induced lymphoid organ atrophy and weight loss by modulating corticosteroid production. Proc Natl Acad Sci USA 2007;104: 14777-14782.
19. Liaw L, Birk DE, Ballas CB et al. Altered wound healing in mice lacking a functional osteopontin gene (SPP1). J Clin Invest 1998; 101: 1468-1478.
20. Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer 2004;90: 1877-1881.
21. Chabas D, Baranzini SE, Mitchell D et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001;294: 1731-1735.
22. Rickard DJ, Sullivan TA, Shenker BJ et al. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994; 161: 218-228.
23. Rittling SR, Matsumoto HN, McKee MD et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 1998;13: 1101-1111.
24. Kazanecki CC, Uzwiak DJ, Denhardt DT. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 2007;102: 912-924.
25. Ren GW, Su JJ, Zhang LY et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009;27: 1954-1962.
26. Xu GW, Zhang LY, Ren GW et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 2007;17: 240-248.
27. Kazanecki CC, Kowalski AJ, Ding T et al. Characterization of anti-osteopontin monoclonal antibodies: Binding sensitivity to posttranslational modifications. J Cell Biochem 2007;102: 925-935.
28. Hu DD, Lin ECK, Kovach NL et al. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 1995;270: 26232-26238.
29. Hruska KA, Rolnick F, Huskey M et al. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology 1995;136: 2984-2992.
30. Yeh WC, Cao Z, Classon M et al. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995;9: 168-181.
31. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006;7: 885-896.
32. Yang HJ, Xia YY, Wang L et al. A novel role for neural cell adhesion molecule in modulating insulin signaling and adipocyte differentiation of mouse mesenchymal stem cells. J Cell Sci 2011;124: 2552-2560.
33. Lin FT, Lane MD. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 1994;91: 8757-8761.
34. Oh KW, Lee WY, Rhee EJ et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol 2005;63: 131-138.
35. Lee NK, Sowa H, Hinoi E et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130: 456-469.
36. Staines KA, MacRae VE, Farquharson C. The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling. J Endocrinol 2012;214: 241-255.
37. Zohar R, Lee W, Arora P et al. Single cell analysis of intracellular osteopontin in osteogenic cultures of fetal rat calvarial cells. J Cell Physiol 1997;170: 88-100.
38. Zohar R, Cheifetz S, McCulloch CAG et al. Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migration. Eur J Oral Sci 1998;106: 401-407.
39. Zohar R, Suzuki N, Suzuki K et al. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 2000;184: 118-130.
40. Segat D, Comai R, Di Marco E et al. Integrins alpha 6A beta 1 and alpha 6B beta 1 promote different stages of chondrogenic cell differentiation. J Biol Chem 2002;277: 31612-31622.
41. Giancotti FG, Ruoslahti E. Transduction-Integrin signaling. Science 1999;285: 1028-1032.
42. Martino MM, Mochizuki M, Rothenfluh DA et al. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 2009;30: 1089-1097.
43. Ge CX, Xiao GZ, Jiang D et al. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 2007;176: 709-718.
44. McCarty RC, Gronthos S, Zannettino AC et al. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol 2009;219: 324-333.
45. Hicok KC, Du Laney TV, Zhou YS et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004;10: 371-380.
46. Gronthos S, Zannettino AC, Hay SJ et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003; 116: 1827-1835.
47. Zheng X, Saunders TL, Camper SA et al. Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 1995;92: 12426-12430.
48. Chapman J, Miles PD, Ofrecio JM et al. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS One 2010;5: e13959.
49. Kiefer FW, Neschen S, Pfau B et al. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 2011;54: 2132-2142.
50. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116: 1793-1801.
51. Nilsson SK, Johnston HM, Whitty GA et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005;106: 1232-1239.
52. Stier S, Ko Y, Forkert F et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005;201: 1781-1791.
53. Calvi LM, Adams GB, Weibrecht KW et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425: 841-846.
54. Zhang JW, Niu C, Ye L et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841.
55. Naveiras O, Nardi V, Wenzel PL et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009;460: 259-263.